
Intermediate Stage Hepatocellular Carcinoma Classifications: the Review
Author(s) -
D. M. Khaitsman,
I. V. Pogrebnyakov,
Э. Р. Виршке,
И. А. Трофимов,
D. Yu. Frantsev,
I. A. Dzhanyan,
В. В. Бредер,
Б. И. Долгушин
Publication year - 2021
Publication title -
onkologičeskij žurnal: lučevaâ diagnostika, lučevaâ terapiâ
Language(s) - English
Resource type - Journals
eISSN - 2713-167X
pISSN - 2587-7593
DOI - 10.37174/2587-7593-2021-4-1-53-64
Subject(s) - hepatocellular carcinoma , stage (stratigraphy) , medicine , liver cancer , cohort , tumor stage , carcinoma , cancer , disease , oncology , liver disease , radiology , biology , paleontology
Hepatocellular carcinoma is the fifth most common cancer worldwide and the approaches to treatmentdiffer due to the stage of the disease. According to BCLC classification, B stage patients are recommendedto be underwent transarterial chemoembolization. However, BCLC B integrates patients with differentintrahepatic tumor burden and with different liver deterioration. There are many staging classifications thatdetermine the treatment and survival rates due to heterogeneity of this patient cohort. The aim of this studyis to review the existing ones and to describe their prognostic value.